Edward Kramer, DO
Neurology · Hot Springs, ARNPI 1992749329
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 316 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 12.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,600 and has fallen 98.6% since, to $22 in 2025.
Across 316 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$724
- Novartis$544
- Amneal Pharmaceuticals LLC$510
- Pfizer$371
- Amgen$331
- Kyowa Kirin, Inc.$326
- plus $3K from 23 others
What the payments were for
- Speaking & faculty fees$110%
- Food & beverage$5,715100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 58 | $724 |
| Novartis | 29 | $544 |
| Amneal Pharmaceuticals LLC | 40 | $510 |
| Pfizer | 23 | $371 |
| Amgen | 18 | $331 |
| Kyowa Kirin, Inc. | 7 | $326 |
| AstraZeneca | 13 | $314 |
| Biogen | 16 | $304 |
| Lilly USA, LLC | 18 | $276 |
| EMD Serono, Inc. | 10 | $259 |
| SK Life Science, Inc. | 11 | $255 |
| Teva Pharmaceuticals USA, Inc. | 13 | $255 |
| UCB, Inc. | 11 | $218 |
| Lundbeck LLC | 10 | $191 |
| Argenx US, Inc. | 7 | $140 |
| Biohaven Pharmaceuticals, Inc. | 1 | $124 |
| Sanofi | 6 | $114 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $108 |
| Tanabe Pharma America, Inc. | 5 | $90 |
| Eisai Inc. | 3 | $55 |
| Neurelis, Inc. | 3 | $50 |
| Avanir Pharmaceuticals, Inc. | 2 | $38 |
| Neurocrine Biosciences, Inc. | 2 | $37 |
| Banner Life Sciences, LLC | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| GE HealthCare | 1 | $16 |
| TG Therapeutics, Inc. | 1 | $16 |
| Catalyst Pharmaceuticals, Inc. | 1 | $12 |
| Acorda Therapeutics, Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NOURIANZ$236
- Mavenclad$125
- NURTEC ODT$124
- ULTOMIRIS$102
How this compares
$5,726 in reported general payments places this provider in the 65th percentile of 93 neurology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LamictalLamotrigine | 11 | $7,570 |
| Lacosamide | 13 | $925 |
| Memantine Hcl | 79 | $910 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 27 | $672 |
| Nortriptyline Hcl | 23 | $516 |
| Primidone | 27 | $415 |
| Duloxetine Hcl | 15 | $360 |
| Lamotrigine | 32 | $307 |
| Gabapentin | 13 | $267 |
| ClopidogrelClopidogrel Bisulfate | 20 | $193 |
| Donepezil Hcl | 29 | $134 |
Paid to pharmacies, not to this prescriber.
Other neurology in Hot Springs
- Kara WayHot Springs$72K
- Anudeep SurendranathHot Springs$4K
- Leonides BermejoHot Springs$3K
- Richard PellegrinoHot Springs$2K
- Kathryn ChenaultSherwood$532K
- Steve-Felix BelingaFort Smith$183K
- Michael MorseFayetteville$149K
- Mark PippengerNorth Little Rock$109K
- Keith SchlutermanConway$67K
- Shitiz SriwastavaLittle Rock$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.